Prevent concomitant usage of tucatinib with CYP3A substrates, where by minimal concentration improvements could lead to critical or existence-threatening toxicities. If unavoidable, lessen CYP3A substrate dose As outlined by item labeling. Abuse and misuse of benzodiazepines typically (but not no